Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Meenan, R. T.
Right arrow Articles by Helfand, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meenan, R. T.
Right arrow Articles by Helfand, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cost-Effectiveness of Echocardiography to Identify Intracardiac Thrombus among Patients with First Stroke or Transient Ischemic Attack

Richard T. Meenan, PhD, MPH

Center for health Research,Portland, Richard.meenan{at}kpchr.org, Center for Health Research, Kaiser Permanente Northwest, Portland, OR, Section of General Internal Medicine, Portland VA Medical Center, Portland, OR

Somnath Saha, MD, MPH

Oregon Health & Science University, Portland, Center for Health Research, Kaiser Permanente Northwest, Portland, OR

Roger Chou, MD

Section of General Internal Medicine, Portland VA Medical Center, Portland, OR

Karleen Swarztrauber, MD, MPH

Department of Neurology, Oregon Health & Science University, Portland

Kathryn Pyle Krages, AMLS, MA

Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, Portland, OR

Maureen C. O'Keeffe-Rosetti, MS

Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, Portland, OR

Marian McDonagh, PharmD

Center for Health Research, Kaiser Permanente Northwest, Portland, OR

Benjamin K. S. Chan, MS

Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, Portland, OR

Mark C. Hornbrook, PhD

Center for Health Research, Kaiser Permanente Northwest, Portland, OR

Mark Helfand, MD, MPH

Section of General Internal Medicine, Portland VA Medical Center, Portland, OR

Background and Purpose . Echocardiography to select stroke patients for targeted treatments, such as anticoagulation (AC), to reduce recurrent stroke risk is controversial. The authors' objective was to evaluate the cost-effectiveness of imaging strategies that use transthoracic (TTE) and transesophageal (TEE) echocardiography for identifying intracardiac thrombus in new stroke patients. Methods . Model-based cost-effectiveness analysis of 7 echocardiographic imaging strategies and 2 nontesting strategies with model parameters based on systematic evidence review related to effectiveness of echocardiography in newly diagnosed ischemic stroke patients (white males aged 65 years in base case). Primary outcome was cost per quality-adjusted life year (QALY). Results. All strategies containing TTE were dominated by others and were eliminated from the analysis. Assuming that AC reduces recurrent stroke risk from intracardiac thrombus by 43% over 1 year, TEE generated a cost per QALY of $137,000 (relative to standard treatment) among patients with 5% thrombus prevalence. Cost per QALY dropped to $50,000 in patients with at least 15% intracardiac thrombus prevalence, or, if an 86% relative risk reduction with AC is assumed, in patients with thrombus prevalence of at least 6%. Probabilistic analyses indicate considerable uncertainty around the cost-effectiveness of echocardiography across a wide range of intracardiac thrombus prevalence (pretest probability). Conclusions . Current evidence on cost-effectiveness is insufficient to justify widespread use of echocardiography in stroke patients. Additional research on recurrent stroke risk in patients with intracardiac thrombus and on the efficacy of AC in reducing that risk may contribute to a better understanding of the circumstances under which echocardiography will be cost-effective. Key words: cost-effectiveness; decision analysis; stroke; transesophageal echocardiography; transthoracic echocardiography; diagnostic imaging. (Med Decis Making 2007;27:161—177)

Medical Decision Making, Vol. 27, No. 2, 161-177 (2007)
DOI: 10.1177/0272989X06297388


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
J. G. Morris, E. J. Duffis, and M. Fisher
Cardiac Workup of Ischemic Stroke: Can We Improve Our Diagnostic Yield?
Stroke, August 1, 2009; 40(8): 2893 - 2898.
[Abstract] [Full Text] [PDF]